Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Orally active iron chelators in development at Novartis

Feb. 16, 1998

Hypocholesterolemic agents disclosed by Warner-Lambert

Feb. 16, 1998

M2 ligands reported for the treatment of dementia

Feb. 16, 1998

Biphenylsulfonamides with MMP-inhibitory effects developed at Warner-Lambert

Feb. 13, 1998

Roche discloses new 5-HT2B antagonists

Feb. 13, 1998

Chiroscience describes series with PDE/TNF-inhibitory properties

Feb. 13, 1998

Pharmacia & Upjohn reveals novel compounds and novel methods of treating NIDDM

Feb. 13, 1998

Nonpeptide GnRH antagonists prepared at Merck & Co.

Feb. 13, 1998

Antipsychotic drugs in development at Janssen

Feb. 13, 1998

DuPont Merck claims new CRF antagonists

Feb. 13, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...